Cohen Milstein Sellers & Toll PLLC Announces the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of IsoRay, Inc.

WASHINGTON, June 18, 2015 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether IsoRay, Inc. ("IsoRay" or the "Company") and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

A class action lawsuit was filed in the U.S. District Court for the Central District of California by another law firm on behalf of purchasers of the common stock of IsoRay (NYSE MKT:ISR) between May 20, 2015 and May 21, 2015, inclusive (the "Class Period"). 

IsoRay develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States.  The company produces Proxcelan Cesium-131 brachytherapy seeds for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. 

Specifically, the Complaint alleges that Defendants misrepresented and/or failed to disclose that: (1) IsoRay's promotional press releases took liberties with clinical data by using clever, selective editing to prop up its stock price and (2) as a result of the foregoing, IsoRay's public statements were materially false and misleading. 

On May 20, 2015, the Company issued a press release titled, "IsoRay's Cesium Lung Cancer Treatment Reports 96% Success in Local Control and 100% Survival at 5 Years in High Risk Patients in Newly Published Report, Cesium-131's Outstanding Lung Cancer Results Take on Other Treatment Forms Including Stereotactic Radiation," which touted the efficacy of its lung cancer treatment using data from a recent study. In response to this release, IsoRay shares jumped from $1.61 to $3.12 on May 20 in extremely heavy trading.

On May 21, 2015, Adam Feuerstein published an article in Street Insider titled "IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price," in which he accused the Company of "tak[ing] liberties with clinical data" and misleadingly publishing only selective results of the study in order to inflate the Company's share price. As a result of this news, IsoRay shares fell from $3.12 to $2.02 on May 21.

Cohen Milstein encourages all investors who purchased IsoRay common stock between May 20, 2015 and May 21, 2015, or former employees with information concerning this matter to contact the firm.

If you are an IsoRay shareholder and would like to discuss your right to recover for your economic loss, you may, without any cost or obligation, call Cohen Milstein's Managing Partner, Steven J. Toll at (888) 240-0775 or (202) 408-4600, or email him at stoll@cohenmilstein.com . If you wish to serve as lead plaintiff, you must move the Court no later than July 21, 2015 to request appointment. Any member of the proposed class may retain Cohen Milstein or other attorneys to serve as your counsel in this action, or you may do nothing and remain an absent class member.

Cohen Milstein has significant experience in prosecuting investor class actions and actions involving securities fraud, and is active in major litigation pending in federal and state courts throughout the nation. Cohen Milstein has taken a lead role in numerous important cases on behalf of defrauded investors, and has been responsible for a number of outstanding recoveries which, in the aggregate, total over two billion dollars. Prior results do not guarantee a similar outcome. For more information, please visit www.cohenmilstein.com .

If you have any questions about this notice or the action, or with regard to your rights, please contact either of the following:

Steven J. Toll, Esq. Rhys Tucker Cohen Milstein Sellers & Toll PLLC 1100 New York Avenue, N.W. West Tower, Suite 500 Washington, D.C. 20005 Telephone: (888) 240-0775 or (202) 408-4600 Email:  stoll@cohenmilstein.com ; rtucker@cohenmilstein.com

Attorney Advertising

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 65

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 108

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Guangdong-US Trade: LED Screens, Beef & Trust Make Waves

Updated Category News Views 29

Guangdong's Economic Ballet with the U.S. Grab a cup of coffee, and let's unravel how Guangdong and the U.S. are tangoing their way through trade like nobody's business! Guangdong, the heavyweight champ for U.S.-China trade transactions, notched up a cool 685.27 billion yuan ($102 billion) in the first eight months of 2026. That's a healthy jump of 6.9% year on year, mind...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 65

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 53

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 164

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 40

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 125

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 115

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 59

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading

Top 5 Most Recently Viewed Articles

Concentrix Unveils Ambitious Sustainability Goals for 2025

Updated Category News Views 366

Concentrix Releases Significant Sustainability Report Concentrix Corporation (NASDAQ: CNXC), a leader in global technology and services, recently revealed its 2025 Sustainability Report titled ‘The Power of One’. This comprehensive document showcases the company’s commitment to achieving its 2030 environmental, social, and governance (ESG) goals. These objectives...

Continue Reading
Hingham Institution for Savings Achieves Remarkable Q3 Growth

Updated Category News Views 193

Summary of Third Quarter Financial Results Hingham Institution for Savings (NASDAQ: HIFS) recently announced its financial results for the quarter ending September 30, 2025, reflecting a significant leap in profitability and growth metrics. The bank’s strategic approach and operational focus have led to these favorable outcomes. Earnings Overview The net income for the...

Continue Reading
Birchtech Corp. Announces Third Quarter Earnings Call Details

Updated Category News Views 149

Birchtech Corp. Announces Third Quarter Earnings Call Details Birchtech Corp. (TSX:BCHT) (OTCQB:BCHT) is making waves in the specialty activated carbon industry. As a recognized leader in technologies for sustainable air and water treatment, this Texas-based company is gearing up for its third-quarter earnings call, scheduled for 5:00 p.m. Eastern Time on a Thursday in...

Continue Reading
Syntec Optics Enhances Product Lines for Next Generation Markets

Updated Category News Views 251

Syntec Optics Promotes Growth in the Satellite Sector Syntec Optics Holdings, Inc. (Nasdaq: OPTX), based in Rochester, New York, is making significant strides in the expanding space market. The company is not just a leader in advanced technology, defense, biomedical, and communications equipment but is now pivoting towards a profound expansion of its space products...

Continue Reading
Laura Celeste Updegraff: Trailblazer in Military Leadership and HR

Updated Category News Views 248

Celebrating Leadership and Achievement Laura Celeste Updegraff, MBA, MS, stands out as a magnificent figure in leadership, recognized within The Inner Circle as a Pinnacle Professional Member Inner Circle of Excellence. Her remarkable journey highlights a deep commitment to service in the U.S. Army and a strong dedication to human resources leadership. A Distinguished...

Continue Reading